Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas.

Humans Receptors, Chimeric Antigen / genetics Ki-1 Antigen Lymphoma Hodgkin Disease / therapy Lymphoma, T-Cell T-Lymphocytes Immunotherapy, Adoptive Receptors, Antigen, T-Cell / genetics
CD30 CD5 CD7 Chimeric antigen receptor T cells Hodgkin lymphoma T-cell non-Hodgkin lymphoma

Journal

Hematology/oncology clinics of North America
ISSN: 1558-1977
Titre abrégé: Hematol Oncol Clin North Am
Pays: United States
ID NLM: 8709473

Informations de publication

Date de publication:
Dec 2023
Historique:
pmc-release: 01 12 2024
medline: 27 11 2023
pubmed: 26 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

The authors review the current use of chimeric antigen receptor (CAR)-transduced T cells (CAR-T) in Hodgkin lymphoma (HL) and T-cell lymphomas (TCL) and discuss the data on CD30-targeting CAR-T cells, which seem to be safe and effective in HL. In addition, the authors examine the use of CAR-T cells targeting CD30, CD5, or CD7 in TCL, while highlighting the unique challenges of their use in this subset of lymphomas. Furthermore, the authors present future directions and ongoing trials investigating the use of CAR-T cells in TCL and HL.

Identifiants

DOI: 10.1016/j.hoc.2023.05.017 PMID: 37357070 PMC: PMC10697615
pubmed: 37357070
pii: S0889-8588(23)00072-2
doi: 10.1016/j.hoc.2023.05.017
pmc: PMC10697615
mid: NIHMS1946190
pii:
doi:

Substances chimiques

Receptors, Chimeric Antigen 0
Ki-1 Antigen 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1107-1124

Subventions

Organisme : NCI NIH HHS
ID : P30 CA125123
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA126752
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Références

Blood. 1991 Apr 1;77(7):1546-54
pubmed: 1826223
Front Oncol. 2022 Nov 29;12:967754
pubmed: 36523990
Blood Adv. 2021 Oct 26;5(20):4291-4302
pubmed: 34610100
Histopathology. 2023 Jul;83(1):143-148
pubmed: 36994939
Clin Cancer Res. 2017 Mar 1;23(5):1156-1166
pubmed: 27582488
Blood. 2011 Jun 23;117(25):6756-67
pubmed: 21493798
J Exp Med. 2004 Dec 20;200(12):1623-33
pubmed: 15611290
Front Oncol. 2023 Mar 03;13:1067289
pubmed: 36937412
Blood. 2022 Jul 28;140(4):321-334
pubmed: 35500125
N Engl J Med. 2022 Jul 28;387(4):310-320
pubmed: 35830649
Blood. 2012 Mar 15;119(11):2644-56
pubmed: 22138512
Adv Cell Gene Ther. 2019 Jul;2(3):
pubmed: 31777773
BMC Cancer. 2019 Mar 6;19(1):203
pubmed: 30841880
Stem Cell Res Ther. 2021 Oct 7;12(1):527
pubmed: 34620233
J Clin Oncol. 2020 Nov 10;38(32):3794-3804
pubmed: 32701411
Blood. 2010 Feb 4;115(5):925-35
pubmed: 19880495
Blood Adv. 2022 Feb 22;6(4):1255-1263
pubmed: 34666347
Nat Rev Drug Discov. 2020 Mar;19(3):185-199
pubmed: 31900462
J Clin Oncol. 2021 Oct 20;39(30):3340-3351
pubmed: 34324392
Nat Med. 2017 Dec;23(12):1416-1423
pubmed: 29131157
N Engl J Med. 2010 Aug 12;363(7):640-52
pubmed: 20818855
J Clin Invest. 2017 Sep 1;127(9):3462-3471
pubmed: 28805662
Front Oncol. 2019 Mar 05;9:126
pubmed: 30891427
Clin Cancer Res. 2022 Jul 1;28(13):2830-2843
pubmed: 35435984
Lancet. 2015 May 9;385(9980):1853-62
pubmed: 25796459
Blood. 2017 Jul 20;130(3):285-296
pubmed: 28539325
Blood. 2016 Sep 22;128(12):1562-6
pubmed: 27432875
Cell Res. 2022 Nov;32(11):995-1007
pubmed: 36151216
Cancer Res. 1998 Mar 15;58(6):1116-9
pubmed: 9515791
Blood Cancer J. 2023 Apr 25;13(1):61
pubmed: 37095094
Blood Adv. 2017 Nov 21;1(25):2348-2360
pubmed: 29296885
Front Immunol. 2021 Mar 03;12:640082
pubmed: 33746981
Blood. 2015 Aug 20;126(8):983-92
pubmed: 26056165
Oncogene. 2002 Apr 11;21(16):2493-503
pubmed: 11971184
Lancet. 2019 Jan 19;393(10168):229-240
pubmed: 30522922
Am J Pathol. 2008 Feb;172(2):510-20
pubmed: 18187570
N Engl J Med. 2011 Nov 3;365(18):1673-83
pubmed: 22047558
J Hematol Oncol. 2018 Nov 27;11(1):132
pubmed: 30482221
Blood. 1991 Sep 1;78(5):1173-82
pubmed: 1878584
Leuk Lymphoma. 1997 Jul;26(3-4):287-98
pubmed: 9322891
Blood. 1986 Sep;68(3):752-61
pubmed: 3488778
J Pers Med. 2022 Feb 01;12(2):
pubmed: 35207685
Blood. 2007 Oct 1;110(7):2620-30
pubmed: 17507664
Leukemia. 2018 Sep;32(9):1970-1983
pubmed: 29483708
Blood. 2009 Jun 18;113(25):6392-402
pubmed: 19377047
Blood Cancer J. 2017 Sep 8;7(9):e603
pubmed: 28885612
Mol Ther. 2023 Jan 4;31(1):24-34
pubmed: 36086817

Auteurs

Ibrahim N Muhsen (IN)

Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.

LaQuisa C Hill (LC)

Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.

Carlos A Ramos (CA)

Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. Electronic address: caramos@bcm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Chimeric Antigen Receptor T Cells in Hodgkin...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Récepteurs cytoplasmiques et nucléaires › Récepteurs chimériques pour l'antigène › Chimeric Antigen Receptor T Cells in Hodgkin...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Antigènes CD30 › Chimeric Antigen Receptor T Cells in Hodgkin...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Chimeric Antigen Receptor T Cells in Hodgkin...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Maladie de Hodgkin › Chimeric Antigen Receptor T Cells in Hodgkin...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Lymphome T › Chimeric Antigen Receptor T Cells in Hodgkin...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Chimeric Antigen Receptor T Cells in Hodgkin...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Immunisation passive › Transfert adoptif › Immunothérapie adoptive › Chimeric Antigen Receptor T Cells in Hodgkin...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Récepteurs aux antigènes › Récepteurs aux antigènes des cellules T › Chimeric Antigen Receptor T Cells in Hodgkin...